Published in JAMA on August 31, 1970
Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care (2003) 4.37
Errors and adverse events in family medicine: developing and validating a Canadian taxonomy of errors. Can Fam Physician (2007) 2.33
The case for recording events in clinical trials. Br Med J (1977) 2.23
Detection of drug-induced disease. Br J Clin Pharmacol (1979) 1.56
Dependence and addiction during chronic opioid therapy. J Med Toxicol (2012) 1.51
Development of a computerized adverse drug event monitor. Proc Annu Symp Comput Appl Med Care (1991) 1.49
Acute adverse reactions attributed to allopurinol in hospitalised patients. Ann Rheum Dis (1981) 1.33
Identification of adverse reactions to new drugs. I: What have been the important adverse reactions since thalidomide? Br Med J (Clin Res Ed) (1983) 1.31
Drug-induced blood dyscrasias in Sweden. Br Med J (1973) 1.30
Prevention of adverse drug events through computerized surveillance. Proc Annu Symp Comput Appl Med Care (1992) 1.26
Drug prescribing in hospitals: an international comparison. Am J Public Health (1976) 1.03
Gentamicin- and cephalothin-associated rises in blood urea nitrogen. Antimicrob Agents Chemother (1976) 0.91
Use of computer-assisted model in diagnosis of drug hypersensitivity jaundice. Br Med J (1973) 0.90
Antibacterial therapy in general medical wards. Postgrad Med J (1977) 0.86
Oral contraceptive use and venous thromboembolism: absence of an effect of smoking. Br Med J (1977) 0.86
Intravenous fluids in medical in-patients. Br J Clin Pharmacol (1977) 0.79
Trends in psychotropic prescribing in general practice and general medical patients. Postgrad Med J (1986) 0.75
Learning how to control biases in studies to identify adverse effects of drugs: a brief personal history. J R Soc Med (2009) 0.75
The changing pattern of toxicity of digoxin. Postgrad Med J (1981) 0.75
Hereford Hospital Prescribing Study: description and usefulness. J R Soc Med (1981) 0.75
Adverse reactions to procainamide. Br J Clin Pharmacol (1977) 0.75
Relationship between medication event rates and the Leapfrog computerized physician order entry evaluation tool. J Am Med Inform Assoc (2013) 0.75
Adverse reactions related to drugs for headache treatment: clinical impact. Eur J Clin Pharmacol (2005) 0.75
Early Lung Cancer Action Project: overall design and findings from baseline screening. Lancet (1999) 13.67
Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst (1982) 13.25
Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA (2001) 11.31
Proportion of disease caused or prevented by a given exposure, trait or intervention. Am J Epidemiol (1974) 9.27
Evidence on screening for breast cancer from a randomized trial. Cancer (1977) 7.91
Estimation of relative risk from individually matched series. Biometrics (1970) 6.47
Risk of upper gastrointestinal bleeding and perforation associated with individual non-steroidal anti-inflammatory drugs. Lancet (1994) 6.40
Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst (1993) 6.02
Periodic breast cancer screening in reducing mortality from breast cancer. JAMA (1971) 5.91
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Histamine-2 receptor antagonists and gastric cancer. Epidemiology (1996) 5.43
Critical variables in the radioimmunoassay of serum insulin using the double antibody technic. Diabetes (1965) 5.42
Mumps, measles, and rubella vaccine and the incidence of autism recorded by general practitioners: a time trend analysis. BMJ (2001) 5.40
Antibiotics and risk of subsequent first-time acute myocardial infarction. JAMA (1999) 5.37
Antidepressants and suicide. BMJ (1995) 4.84
Stratification by a multivariate confounder score. Am J Epidemiol (1976) 4.58
Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA (1989) 4.52
Confounding: essence and detection. Am J Epidemiol (1981) 4.47
Postmarketing follow-up at Group Health Cooperative of Puget Sound. Pharmacotherapy (1984) 4.39
Standardization of risk ratios. Am J Epidemiol (1972) 4.32
Intracellular enzymes in local lymph as a measure of cellular injury. J Physiol (1967) 4.22
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product. Lancet (1996) 4.21
Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial. Ann Intern Med (2000) 4.07
HMG-CoA reductase inhibitors and the risk of fractures. JAMA (2000) 3.91
Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA (1993) 3.71
The reluctant participant in a breast cancer screening program. Public Health Rep (1968) 3.60
Utilization of health and mental health services. Three Epidemiologic Catchment Area sites. Arch Gen Psychiatry (1984) 3.55
A comparison of the requirements for primary care physicians in HMOs with projections made by the GMENAC. N Engl J Med (1986) 3.54
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives. Lancet (2001) 3.48
Cigarette smoking and ulcerative colitis. N Engl J Med (1983) 3.47
Urokinase-generated plasmin activates matrix metalloproteinases during aneurysm formation. Nat Genet (1997) 3.40
Antipsychotic drug use and risk of first-time idiopathic venous thromboembolism: a case-control study. Lancet (2000) 3.35
Effect of questionnaire design on recall of drug exposure in pregnancy. Am J Epidemiol (1986) 3.34
Five-year blood pressure control and mortality following health education for hypertensive patients. Am J Public Health (1983) 3.33
The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol (1990) 3.32
Addiction rare in patients treated with narcotics. N Engl J Med (1980) 3.20
Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore. Arch Gen Psychiatry (1985) 3.18
Lymph flow and changes in intracellular enzymes during healing and rejection of rabbit skin grafts. J Physiol (1971) 3.05
Oral-contraceptive use in relation to myocardial infarction. Lancet (1979) 3.04
An alternative to the proportionate mortality ratio. Am J Epidemiol (1981) 3.03
The need for randomization in the study of intended effects. Stat Med (1984) 3.01
Efficacy and toxicity of heparin in relation to age and sex. N Engl J Med (1968) 2.99
Concern Early lung cancer action project: initial findings on repeat screenings. Cancer (2001) 2.99
A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer. J Natl Cancer Inst (1991) 2.96
Mammography and clinical examination in mass screening for cancer of the breast. Cancer (1967) 2.80
Functional recovery and medical costs of trauma: an analysis by type and severity of injury. J Trauma (1988) 2.74
Drug surveillance utilizing nurse monitors. An epidemiological approach. Lancet (1966) 2.69
Changes in the composition of rabbit hind limb lymph after thermal injury. J Physiol (1969) 2.66
Effects of indomethacin in premature infants with patent ductus arteriosus: results of a national collaborative study. J Pediatr (1983) 2.65
Replacement estrogens and endometrial cancer. N Engl J Med (1979) 2.65
Antenatal exposure to doxylamine succinate and dicyclomine hydrochloride (Benedectin) in relation to congenital malformations, perinatal mortality rate, birth weight, and intelligence quotient score. Am J Obstet Gynecol (1977) 2.65
The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med (1985) 2.64
Individual matching with multiple controls in the case of all-or-none responses. Biometrics (1969) 2.58
Induction of an active transport system for glucose 6-phosphate in Escherichia coli. Arch Biochem Biophys (1966) 2.53
Mental health and social characteristics of the homeless: a survey of mission users. Am J Public Health (1986) 2.50
Drug rash with ampicillin and other penicillins. Lancet (1969) 2.50
SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo. Proc Natl Acad Sci U S A (2001) 2.49
A case-control study of baldness in relation to myocardial infarction in men. JAMA (1993) 2.49
Drugs--remarkably nontoxic. N Engl J Med (1974) 2.43
The estimation of oxygen consumption. Cardiovasc Res (1970) 2.40
Rat pulmonary circulation after chronic hypoxia: hemodynamic and structural features. Am J Physiol (1979) 2.40
Acute respiratory-tract infections and risk of first-time acute myocardial infarction. Lancet (1998) 2.39
Noninvasive tests in the initial evaluation of heart murmurs in children. N Engl J Med (1983) 2.39
Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet (1969) 2.38
Impact of efforts to increase participation in repetitive screenings for early breast cancer detection. Am J Public Health (1972) 2.35
Breast cancer and cigarette smoking: a hypothesis. Am J Epidemiol (1991) 2.35
Statin use and cancer risk in the General Practice Research Database. Br J Cancer (2004) 2.34
Inhibition of release of prostaglandins as an explanation of some of the actions of anti-inflammatory corticosteroids. Nature (1975) 2.33
Race, family income, and low birth weight. Am J Epidemiol (1991) 2.30
The discovery of drug-induced illness. N Engl J Med (1977) 2.29
Components of the crude risk ratio. Am J Epidemiol (1972) 2.25
Apoptotic photoreceptor degeneration in experimental retinal detachment. Invest Ophthalmol Vis Sci (1995) 2.24
Current practice of artificial insemination by donor in the United States. N Engl J Med (1979) 2.24
Medical economics survey-methods study: cost-effectiveness of alternative survey strategies. Med Care (1978) 2.22
The action of angiotensin and bradykinin on the superior cervical ganglion of the cat. J Physiol (1965) 2.20
Dexamethasone and dexamethasone-aspirin in the treatment of chronic rheumatoid arthritis. A controlled trial. Lancet (1965) 2.18
The incidence of breast cancer in the General Practice Research Database compared with national cancer registration data. Br J Cancer (2000) 2.17
Limited Pap screening associated with reduced risk of cervical cancer in South Africa. Int J Epidemiol (2003) 2.17
A multicenter, randomized, double-blinded trial of pyridostigmine in postpolio syndrome. Neurology (1999) 2.16
The search for risk factors in breast cancer. Am J Public Health Nations Health (1968) 2.16
The economic impact of traumatic injuries. One-year treatment-related expenditures. JAMA (1988) 2.15
Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins]. Proc Natl Acad Sci U S A (1980) 2.13
Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data. Am J Obstet Gynecol (1989) 2.12
The Abbreviated Injury Scale and Injury Severity Score. Levels of inter- and intrarater reliability. Med Care (1985) 2.11
Methyl-coenzyme M, an intermediate in methanogenic dissimilation of C1 compounds by Methanosarcina barkeri. J Bacteriol (1980) 2.11